Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, and Versant Diagnostics, an independent physician services company actively engaged in next-generation digital pathology, announce an expanded collaboration to advance digital pathology adoption. PRW Laboratories, in partnership with Versant Diagnostics and Versant DermPath, has become the world’s first laboratory to deploy the recently launched Aperio GT Elite solution.
Designed for high-throughput, time-critical digital pathology workflows, the Aperio GT Elite scanner helps accelerate slide processing and review with minimal manual intervention and rework. It can scan as fast as 22 seconds per slide and integrate LIS data to drive automated scanning protocols based on criteria such as tissue or stain type.
“For digital pathology to truly advance, innovation must translate into faster, more confident decisions for laboratories and ultimately, the patients they serve,” said Naveen Chandra, Vice President and General Manager of Digital Pathology at Leica Biosystems. “With the Aperio GT Elite, we are leveraging our deep pathology expertise to help customers move from slide to insight faster through a connected, high-throughput workflow that reduces manual steps and adapts to their real-world needs. This launch reflects our long-term commitment to delivering scalable, end-to-end solutions that enable labs to adopt digital pathology with confidence and accelerate the impact of every review.”
The deployment reflects growing adoption of high-throughput, AI-enabled digital pathology workflows and builds on a longstanding collaboration between Leica Biosystems and Versant Diagnostics. Before adding the Aperio GT Elite solution, Versant Diagnostics leveraged the Leica Biosystems Aperio GT 450 scanner to digitize whole-slide images, alongside Indica Labs’ HALO AP® document as their image management solution.
"When we started our digital journey, we weren’t simply looking for an equipment vendor—we were looking for a true partner who shared our vision for the future of patient care,” said Lola Leibensperger, Versant Diagnostics’ Chief Operating Officer. “Becoming the first laboratory network in the world to implement Leica Biosystems' Aperio GT Elite scanners at Versant Diagnostics and PRW Laboratories is a testament to that shared commitment. This milestone isn't just about adopting cutting-edge technology; it's about pioneering digital innovation together to enhance accuracy, streamline laboratory workflows, and ultimately deliver faster, more precise diagnostics for the patients who depend on us."
“As digital pathology hardware and software continue to evolve rapidly, selecting a vendor is about more than choosing the best solutions available today—it is also about partnering with an organization that can provide ongoing access to innovation and support,” said Clay Hillyer, Senior National Sales Director at Leica Biosystems. “As a global leader in digital pathology, Leica Biosystems is committed to delivering both advanced products and a robust innovation pipeline that helps customers deploy and scale digital pathology to its fullest potential. We are proud to continue that commitment to Versant Diagnostics and PRW Laboratories through this deployment of the Aperio GT Elite solution.”
The Aperio GT Elite solution is one of the most recent innovations within Leica Biosystems’ comprehensive digital and computational pathology ecosystem and expands the company’s portfolio of end-to-end solutions–the only provider in the industry to span the full anatomic pathology workflow. Leica Biosystems is trusted by 100% of the Top 50 Hospitals for Cancer, as well as the National Cancer Institute‑Designated Cancer Centers, and holds the largest digital pathology instrument install base worldwide.
With planned expansion and broader availability of the Aperio GT Elite solution across additional global markets, Leica Biosystems continues to enable access to high-performance digital pathology solutions worldwide.
